Incannex Healthcare Ltd ADR (IXHL NASDAQ) stock market data APIs
$0.5256
-0(-0%)
as of September 17, 2025
Try our APIs with
free plan!
Incannex Healthcare Ltd ADR Financial Data Overview
Price chart is built with
Anychart
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that has completed Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate in Phase 2 clinical trial to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia.
Prev. Close
0.5256
Open
0.5226
High
0.5351
Low
0.5133
52 wk Range
0.08-3.12
Market Cap
49 462 K
Shares Outstanding
93 695 K
Revenue
98 000
EPS
-0.31
Beta
2.712
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Incannex Healthcare Ltd ADR data using free add-ons & libraries
Get Incannex Healthcare Ltd ADR Fundamental Data
Incannex Healthcare Ltd ADR Fundamental data includes:
- Net Revenue: 98 000
- EBITDA: -20 286 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-15
- EPS/Forecast: -0.72
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Incannex Healthcare Ltd ADR News
New
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Green Thumb Sold Iconic Brands to Agrify, Which Will Rebrand as RYTHM, Inc. MTL Cannabis Delivered Steady Q1 2026 Results and Launched Major Expansion Projects Simply S...
Check out the stocks that are attracting the most attention and driving market activity.
Friday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity! [mostactive] TOP MOST ACTIVE STOCKS TICKER CHANGE COMMENT ...
These stocks are the most active in today's session
Curious about the most active stocks on Thursday? Find out which stocks are dominating the market action! [mostactive] TODAY'S MOST ACTIVE STOCKS TICKER CHANGE COMMENT RAYA [https://www....
These stocks are making the most noise in today's session.
Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action! [mostactive] TODAY'S MOST ACTIVE STOCKS TICKER CHANGE COMMENT WAI [https://www....
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
